ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Aminotetrazole-Gold Nanocomplexes Shunt Electrons to Eradicate Bacteria Without ROS-Induced Resistance.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Most bactericides directly or indirectly disrupt the electron transport chain (ETC)-mediated energy metabolism to exert antibacterial effects. However, the consequent perturbation of electron transfer states (e.g., flux overload or blockade) leads to electron accumulation, which enhances reactive oxygen species (ROS) generation. High ROS concentrations kill bacteria, while sublethal levels induce DNA damage, thereby elevating antibiotic resistance risk. In this study, we found that shunting electrons at critical ETC nodes is able to disrupt bacterial energy metabolism, damaging bacteria without ROS generation. To leverage the ROS-free mechanism for infection control, we synthesized 5-aminotetrazole-functionalized gold nanocomplexes (ATZ-Au) that intercept electron transfer from electron donors to downstream carriers. This rapidly depletes reduced nicotinamide adenine dinucleotide (NADH), disrupts the proton motive force (PMF), impairs ATP synthesis, and blocks bacterial compensatory metabolic pathways, ultimately leading to lethal intracellular acidosis and metabolic collapse. This effect blocks the capture of electrons by oxygen, thereby preventing the generation of ROS. The ATZ-Au efficiently eliminates pathogenic bacteria in complex infections, providing a promising strategy to address antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.